COMMUNIQUÉS West-GlobeNewswire

Aptose Reports Results for the Second Quarter Ended June 30, 2018

07/08/2018 - 22:18

Conference Call and Webcast at 5pm EDT Today SAN DIEGO and TORONTO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing [...]

Aileron Therapeutics Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:15

Preclinical in-vivo ALRN-6924 combination data with CDK4/6 inhibitors, PD-1/-L1 inhibitors, or paclitaxel (formulated as Abraxane or Taxol) all show promise in breast cancer and other cancer models Initiation of [...]

Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent Developments

07/08/2018 - 22:15

MENLO PARK, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Versartis, Inc . (Nasdaq:VSAR) today announced financial results for the second quarter ended June 30, 2018 and provided a review of recent corporate activities. “We [...]

Supernus Announces Second Quarter 2018 Financial Results and Record Quarterly Revenue

07/08/2018 - 22:15

Total revenue of $99.5 million, a 31% increase over 2017 Net product sales of $97.0 million, a 32% increase over 2017 Operating earnings of $35.7 million, a 37% increase over 2017 Diluted earnings per share (GAAP) of $0 [...]

Calithera Biosciences Reports Second Quarter 2018 Financial Results and Recent Highlights

07/08/2018 - 22:08

- Two Novel Programs Entering Clinical Development -Calithera to Host Conference Call Today at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Calithera [...]

Alder BioPharmaceuticals® Reports Second Quarter 2018 Financial and Operating Results

07/08/2018 - 22:07

- Presented new eptinezumab Phase 3 clinical trial data in episodic and chronic migraine demonstrating robust efficacy that is sustained and further improved after repeat quarterly treatments - - Biologics License [...]

Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights

07/08/2018 - 22:07

Clinical data updates and regulatory feedback for VY-AADC during the quarter support planned pivotal program for Parkinson’s disease Pipeline programs progressing with updated preclinical data from ALS and Huntington’s [...]

Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018

07/08/2018 - 22:05

Conference call at 8:30 a.m. EDT, Tuesday, August 14, 2018 RUTHERFORD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for oncology through molecular [...]

Kura Oncology to Present at 2018 Wedbush PacGrow Healthcare Conference

07/08/2018 - 22:05

SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]

Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update

07/08/2018 - 22:05

Net loss was $59.9 million in the second quarter and $108.6 million for the first six months ended June 30, 2018 Net cash from operating and investing activities was $58.0 million in the second quarter and $26.3 million [...]

GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference

07/08/2018 - 22:05

SOUTH SAN FRANCISCO, Calif. , Aug. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 2018 Wedbush PacGrow Healthcare Conference in New York City [...]

Athersys Reports Second Quarter 2018 Results

07/08/2018 - 22:05

Management to host conference call at 4:30pm EDT today CLEVELAND, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended June 30, 2018. [...]

miRagen Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update

07/08/2018 - 22:05

Cobomarsen expansion indication data released; first observations from the ongoing Phase 1 clinical trial on safety and efficacy of cobomarsen in ATLL patients, additional data expected by year end New cobomarsen Phase [...]

MRI Interventions, Inc. to Announce Second Quarter 2018 Results on August 14

07/08/2018 - 22:05

IRVINE, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced that it will release financial results for its 2018 second quarter, which ended June 30, 2018, on Tuesday, August 14, 2018 [...]

Inovio Pharmaceuticals Reports 2018 Second Quarter Financial Results

07/08/2018 - 22:05

PLYMOUTH MEETING, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a late-stage biotechnology company focused on the development and commercialization of DNA immunotherapies targeted [...]

Sunesis Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Highlights

07/08/2018 - 22:05

Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the quarter [...]

Inspire Medical Systems, Inc. Announces Second Quarter 2018 Financial Results

07/08/2018 - 22:05

MINNEAPOLIS, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Axovant Announces First Fiscal Quarter 2018 Financial Results and Corporate Update

07/08/2018 - 22:05

Pipeline expanded with gene therapy technologies including AXO-Lenti-PD for treatment of Parkinson’s Disease and AXO-AAV-OPMD for treatment of oculopharyngeal muscular dystrophy Ilise Lombardo, MD, promoted to Chief [...]

Zafgen Reports Second Quarter 2018 Operating and Financial Results

07/08/2018 - 22:05

Phase 1 clinical trial for ZGN-1258 for Prader-Willi syndrome (PWS) expected to begin in the fourth quarter 2018 Multiple ZGN-1258 nonclinical studies accepted for presentation at upcoming Foundation for Prader-Willi [...]